Salih Serin

Dr. Salih Serin


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2019 in The European Research Journal
Verified
Journal Article
Open access
PDF file
HKHakan Kıran
Hakan Kıran
Murat AralMurat Aral
Murat Aral
GKGürkan Kıran
Gürkan Kıran
SSSalih Serin
Salih Serin
DADeniz Cemgil Arıkan
Deniz Cemgil Arıkan
HEHasan Çetin Ekerbiçer
Hasan Çetin Ekerbiçer
Objectives: Nosocomial outbreaks of infection originating from ultrasound probes and contaminated coupling gels have been reported. It was reported that the ultrasound probe, if cultured after routine scanning of intact skin, may become colonized with skin flora.Methods: Culture swabs from 22 probes of the 9 ultrasound machines and from the gels in the 10 gel folders were taken. All swabs taken from probe head, probe holder and the coupling gel in the folder at the beginning of the day were cultured. After fifth scanning and after wiping off the gel with a dry, nonsterile paper towel, cultures were again obtained from probe head and probe holder.Results: A total of 98 culture results were included of which 42.8% were positive for bacterial growth. The rate of bacterial contamination from probes at morning before the start of examination and after scanning were 34.1% and 56.8%, respectively and this difference was statistically significant (p = 0.023). Conclusions: We think that using nonsterile, dry, soft and absorbent paper towel after each procedure, could be inadequate for disinfection of probe head. Especially, good hand hygiene could decrease the rate of growth of bacterial colony at probe handle.

10 November 2022 in Phoenix Medical Journal
Verified
Journal Article
Open access
FAFazıl AVCI
Fazıl AVCI
GKGürkan Kiran
Gürkan Kiran
HKHakan Kiran
Hakan Kiran
SSSalih Serin
Salih Serin
Aim: The purpose of this study is to present the importance of hemoperitoneum and retrospective analysis of tubal ectopic pregnancy cases treated in our clinic. Material and Methods: This study respectively included 86 women who were diagnosed and treated for tubal ectopic pregnancy (EP) in our single-centre clinic between January 2012 and August 2013. Age, date of last menstrual period, human chorionic gonadotropin (β-hCG) level, the size and the presence of tubal EP masses, fetal cardiac activity and treatment procedures were evaluated and compared. The presence of hemoperitoneum for predictive treatment methods and factors that affecting the success of treatment methods were investigated. Results: The mean age of the patients was 29.1±5.7 (16-41) years. Mean β-hCG level was 4448,5±8351,9 IU/L. Laparatomy was performed to 14 patients (16.3%), laparoscopy to 5 patients (5.8%), expectant management to 15 patients (17.4%). Methotrexate (MTX) treatment was given to 46 patients (53.5%) and laparoscopy was performed to 1 patient (1.2%) and laparatomy to 5 patients (5.8%) due to MTX treatment failure in 6 patients. Compared with the MTX treatment of tubal EP, the possible factors that affecting surgical management, such as the initial β-hCG level (p=0.004), whether there is hemorrhage in the abdominal cavity (p=0.03), the size of ectopic pregnancy mass (p=.005) and the presence of fetal heart activity (p

18 June 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SSSalih Serin
Salih Serin
HCHamdiye Celikaslan
Hamdiye Celikaslan
SCSibel Cangi
Sibel Cangi
Recep DokuyucuRecep Dokuyucu
Recep Dokuyucu
Polycystic ovary syndrome (PCOS) is characterized by insulin resistance, hyperandrogenism, oxidative stress, and disrupted folliculogenesis. The present study aimed to investigate whether combined alpha-lipoic acid (ALA) and vitamin D therapy exerts synergistic effects on metabolic, oxidative, endocrine, and histomorphological parameters in a letrozole-induced rat model of PCOS. Sixty female Wistar Albino rats were randomly divided into six groups: Control, PCOS, PCOS+Metformin (500 mg/kg/day), PCOS+Vitamin D (1000 IU/kg/day), PCOS + ALA (100 mg/kg/day), and PCOS + ALA+Vitamin D. PCOS was induced with letrozole (1 mg/kg/day) for 21 days, followed by 30 days of treatment. Fasting blood glucose (FBG), insulin, and HOMA-IR were assessed to evaluate metabolic status. Ovarian oxidative stress markers (MDA, SOD, CAT, GSH), serum hormonal parameters (testosterone, LH, FSH, LH/FSH ratio), and detailed histomorphometric analyses were performed. Statistical analyses included one-way and two-way ANOVA. Letrozole administration induced persistent diestrus, hyperandrogenemia, increased ovarian weight, elevated HOMA-IR (6.61 ± 1.18 vs. 2.24 ± 0.42, p < 0.001), and marked oxidative stress (MDA: 5.84 ± 0.72 vs. 2.31 ± 0.34 nmol/mg, p < 0.001). ALA and vitamin D monotherapies significantly improved metabolic, oxidative, and endocrine parameters compared with untreated PCOS rats (p < 0.05). The combination therapy group demonstrated the most pronounced improvements, with HOMA-IR (2.43 ± 0.47), MDA (2.52 ± 0.39 nmol/mg), testosterone (1.29 ± 0.27 ng/mL), and LH/FSH ratio (1.03 ± 0.19) values approaching control levels (all p < 0.01 vs. PCOS). Histologically, combined treatment markedly reduced cystic follicles and restored granulosa and theca thickness. Two-way ANOVA revealed significant interaction effects for HOMA-IR, MDA, testosterone, and LH/FSH ratio (p < 0.05). Combined ALA and vitamin D therapy produced enhanced improvements in insulin resistance, oxidative stress, endocrine imbalance, and ovarian morphology in experimental PCOS. Simultaneous targeting of mitochondrial redox dysfunction and endocrine–metabolic signaling pathways may represent a promising multidimensional therapeutic approach in PCOS.